article thumbnail

DEA Seizes 4M Marijuana Plants, Less Arrests in ’19

CannaMD

Drug Enforcement Agency (DEA) made far fewer cannabis-related arrests in 2019 than in previous years. Let’s take a closer look at what DEA data reveals. But despite all the DEA’s seizing and destroying, it’s clear that the average U.S. That’s what DEA data indicates, at least — especially when looked at closely.

DEA 59
article thumbnail

New Frontiers in the Law of Psychedelics

Cannabis Law Report

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. The state of the law on psychedelic substances is in flux. Id ; 21 CFR 312.1-10; 10; 312.80-88;

Law 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What is the Difference Between a Cannabis Recommendation and Cannabis Prescription

United Patients Group

Epidiolex, an FDA-approved medication containing CBD (cannabidiol), has been listed as Schedule 5 by the DEA since June 25th, 2019. The doctor who writes the prescription must be licensed and has to write it for a specific patient, as opposed to prescribing general instructions for treatment. Cannabis is a schedule 1 substance.

DEA 52
article thumbnail

Doctor Takes on Marijuana Myths in New Book

Cannabis Law Report

The book, “The Brain on Cannabis: What You Should Know About Recreational and Medical Marijuana,” came out in late 2021. Marijuana myths continue to keep people from trying medical marijuana as a treatment. She now has written a book that focuses on dispelling those marijuana myths conjured up by cannabis opponents over the years.

article thumbnail

Analysts Envision a $33.2 Billion Medical Cannabis Market By 2027

Veriheal

D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted. Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate.

article thumbnail

Oregon Psilocybin: Does Measure 109 Go Far Enough? Does it Go Too Far?

Canna Law Blog

Still, even if the FDA approves a psilocybin drug and the Drug Enforcement Administration (DEA) reschedules the compound, the legal paradigm will be similar to what we see today: psilocybin will be classified as a controlled substance, unlawful prescribe without a DEA license. The Oregon program will not square with federal laws.

DEA 80
article thumbnail

CBD: Everything You Need to Know

CannaMD

Hemp is often used in manufacturing; whereas marijuana serves a primarily medicinal/recreational purpose. For example, the DEA considers Schedule I drugs to have a “high potential for abuse and the potential to create severe psychological and/or physical dependence.” One more difference? CBD Scheduling Rule Change. What can CBD do?

CBD 99